Achieve Life Sciences Inc
Research Achieve Life Sciences Inc (ACHV) on Bullrun: market cap USD 839.20M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACHV
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 839.20M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 10.17M
- Free cash flow-USD 6.93M
Valuation Snapshot
latest market cap is USD 839.20M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 54.65M | -USD 49.47M | n/a | -1.25 | USD 20.93M | USD 14.96M | USD 21.52M |
| FY2024 | USD 0 | -USD 39.83M | -USD 29.77M | n/a | -1.24 | USD 12.75M | USD 9.96M | USD 20.90M |
| FY2023 | USD 0 | -USD 29.82M | -USD 24.50M | n/a | -1.5 | USD 15.55M | USD 16.73M | -USD 1.45M |
| FY2022 | USD 0 | -USD 41.88M | n/a | n/a | -4 | USD 24.77M | USD 15.50M | USD 8.30M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 839.20M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 264.57M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 122.09M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 87.20M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 43.85M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 73.55M | n/a | n/a | n/a |
About Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Achieve Life Sciences Inc's market cap?
Achieve Life Sciences Inc's market capitalization is USD 839.20M.
What does Achieve Life Sciences Inc do?
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.